Showing results (1801-1810 of 2,014) with videos related to

Sort By:
Pageof 202
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
RSC Medicinal Chemistry|August 6, 2021
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid propertiesGiselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients' Characteristics, Comorbidity Profiles and Treatment PatternsEdoardo Giovanni Giannini, Alessandra Mangia, Filomena Morisco, et al.
Nature Communications|October 6, 2020
Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activityE Bartolini, E Borgogni, M Bruttini, et al.
Epilepsy & Behavior : E&B|February 12, 2021
Climate change and epilepsy: Insights from clinical and basic science studiesMedine I Gulcebi, Emanuele Bartolini, Omay Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Single-nucleus multiomics in brains from Hispanic individuals reveal <i>APOE-ε4</i> -driven disruption of focal adhesion signaling in the presence of cerebrovascular pathologyElanur Yilmaz, Kevin W Chen, Elif Öykü Cakir, et al.
Nature Communications|December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerBeth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Journal of Medicinal Chemistry|March 10, 2022
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's DiseaseSandra Codony, Caterina Pont, Christian Griñán-Ferré, et al.
ACS Chemical Neuroscience|April 2, 2021
(±)-<b>BIGI-3h</b>: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's DiseaseLhassane Ismaili, Julie Monnin, Adeline Etievant, et al.
Pageof 202